Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NC-1153: a novel immunosuppressant that selectively targets Jak3

June 3, 2003

Orally active, small-molecule CXCR3 antagonist represents a new class of transplant therapeutics

June 3, 2003

Multiferon use expanded in Mexico

June 2, 2003

Valentis licenses delivery technology to Juvaris

May 26, 2003

New immunosuppressive compound under development at Isotechnika

May 23, 2003

Immune-selective proteasome inhibitors under study at Kyorin and Nisshin Pharma

May 22, 2003

Thalidomide delays sepsis in an experimental model

May 22, 2003

New IMPDH inhibitors, their preparation and use reported by Celltech R&D

May 20, 2003

Regulatory approval sought for Fendrix

May 15, 2003

Ciclosporin analogues for autoimmune diseases designed at Enanta

May 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...